Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Moodys
Colorcon
AstraZeneca
Baxter

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for Forest Laboratories, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

See Plans and Pricing

« Back to Dashboard

Forest Laboratories, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-10-20
Court District Court, D. Delaware Date Terminated 2018-05-14
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties ALLERGAN USA, INC.; FOREST LABORATORIES HOLDINGS, LTD.; FOREST LABORATORIES, LLC; IRONWOOD PHARMACEUTICALS, INC.; TEVA PHARMACEUTICALS USA, INC.
Patents 7,304,036; 7,371,727; 7,704,947; 7,745,409; 8,080,526; 8,110,553; 8,748,573; 8,802,628; 8,933,030; 9,708,371
Attorneys Jack B. Blumenfeld; Karen Elizabeth Keller; Maryellen Noreika
Firms Morris, Nichols, Arsht & Tunnell; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Forest Laboratories, LLC v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Forest Laboratories, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 States Patent Nos. 7,304,036 ("the '036 patent"), 7,371,727 ("the '727 patent"…;036 patent, the '727 patent, the '947 patent, the '409 patent, the '526 patent, the …;036 patent, the '727 patent, the '947 patent, the '409 patent, the '526 patent, the …the '553 patent, the '573 patent, the '628 patent, and the '030 patent are invalid, unenforceable…the '553 patent, the '573 patent, the '628 patent, and the '030 patent no earlier than External link to document
0000-00-00 11 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,708,371 B2. (Attachments: #… 2017 14 May 2018 1:17-cv-01481 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,708,371 B2. (nmfn) (Entered… 2017 14 May 2018 1:17-cv-01481 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Medtronic
AstraZeneca
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.